Quantcast

Latest leukemia Stories

2014-09-02 12:28:40

Home Decor Retailer Launches National In-Store Fundraiser and Sponsors Light The Night Walks to Support Cancer Cures PLANO, Texas, Sept. 2, 2014 /PRNewswire/ -- At Home, the home decor superstore, announced today a national partnership with The Leukemia & Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to finding cures for blood cancers. Throughout the month of September, Blood Cancer Awareness Month, At Home team members will be collecting $1, $5...

2014-08-28 08:27:53

WHITE PLAINS, N.Y., Aug. 28, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) and OncoPep have entered a partnership to advance an experimental cancer vaccine to treat patients with smoldering multiple myeloma (SMM), an asymptomatic stage of myeloma. The partnership is through LLS's Therapy Acceleration Program® (TAP), through which LLS forges collaborations with biotechnology companies to help bring therapies to patients faster. OncoPep is developing a...

2014-08-27 08:27:52

The Leukemia & Lymphoma Society to Raise $300,000 during September, Blood Cancer Awareness Month WHITE PLAINS, N.Y., Aug. 27, 2014 /PRNewswire/ -- Every three minutes, someone in the U.S. is diagnosed. More than 1.1 million Americans are living with, or in remission from, these diseases. Certain forms of these diseases are the most common types of cancer in children and adolescents younger than 20 years. Almost 150,000 Americans will be diagnosed with these cancers this year. There are few,...

2014-08-26 23:13:53

CEHN’s Childhood Leukemia Fact Sheet, which provides tips on how to reduce exposure to environmental risk factors associated with childhood leukemia, is now available in Spanish. Washington, DC (PRWEB) August 26, 2014 The Children’s Environmental Health Network’s (CEHN) Childhood Leukemia Fact Sheet, created with the University of California at Berkeley’s Center for Integrative Research on Childhood Leukemia and the Environment (CIRCLE), has been translated and is now available in...

kidney stone
2014-08-18 03:45:20

Caroline Arbanas, Washington University in St. Louis Anyone who has suffered from kidney stones is keenly aware of the lack of drugs to treat the condition, which often causes excruciating pain. A new mouse study, however, suggests that a class of drugs approved to treat leukemia and epilepsy also may be effective against kidney stones, researchers at Washington University School of Medicine in St. Louis report. The drugs are histone deacetylase inhibitors, or HDAC inhibitors for...

2014-08-07 20:24:36

Leukotuximab is a novel, first-in-class Leukemia-specific mAb targeting JL-1 SHENYANG, China, Aug. 7, 2014 /PRNewswire/ -- 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with DiNonA Inc. for the development, manufacturing and marketing of Leukotuximab, an anti JL-1 antibody for acute leukemia (AL), including acute myelocytic...

2014-08-06 16:28:42

Input will help shape the role of public contributions to orphan drug approvals OTTAWA, Aug. 6, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, announced today that the Government of Canada has launched a pilot project targeting patient input from Canadians with rare diseases to help inform future reviews of orphan drugs. As announced in October of 2012, Health Canada has been developing an Orphan Drug Framework to spur innovation and research into new treatments...

2014-08-01 12:26:16

CHICAGO, Aug. 1, 2014 /PRNewswire-USNewswire/ -- The groundbreaking scientific studies featured at the 2014 AACC Annual Meeting & Clinical Lab Expo will include research on a blood test for Alzheimer's that uses biochip technology, a new test to diagnose colon cancer early, a more accurate method for determining multiple myeloma prognosis, a less stressful test for sleep apnea, and the development of a bank of biospecimens from pregnant women that could prove crucial for women's...

2014-07-31 16:28:44

- IMBRUVICA Net Product Revenue Increased to $109.5 million for the Second Quarter of 2014 - SUNNYVALE, Calif., July 31, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today reported financial results and recent developments for the quarter ended June 30, 2014. Financial Results for the Six Months and Quarter Ended June 30, 2014 Revenue Total revenue for the quarter ended June 30, 2014 increased to $113.0 million from $54.7 million for the quarter ended June 30,...

2014-07-29 12:35:55

The "Light The Night" Campaign has raised more than $2 million over 7 years SAN BERNARDINO, Calif., July 29, 2014 /PRNewswire/ -- Stater Bros. Charities and The Leukemia & Lymphoma Society (LLS) concluded another successful "Light The Night" fundraising campaign in support of LLS' mission to find cures and ensure access to treatments for blood cancer patients. These funds will also help LLS invest in research to advances cures for blood cancers....


Latest leukemia Reference Libraries

Clinical Leukemia
2012-05-18 15:34:28

Clinical Leukemia is a peer-reviewed medical journal published by CIG Media Group. The journal publishes articles on detection, diagnosis, prevention, and treatment of leukemia. The main emphasis is on recent scientific developments in all areas related to leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance, gene and antisense therapy; pathology, markers, and prognostic indicators, chemoprevention strategies,...

More Articles (1 articles) »
Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'